John Libbey Eurotext

VEGF Actu

Vaccination anti-VEGFA Comment combiner le ciblage de l’angiogenèse et l’immunothérapie Volume 12, issue 1, Mars 2017

Figures

Author
1 Université de Bordeaux, Inserm U1218, Bordeaux, France

Wentink et al. Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity. Proc Natl Acad Sci USA 2016; 113: 12532-7.